On Monday, 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) was -20.55% drop from the session before settling in for the closing price of $0.7. A 52-week range for SXTP has been $0.65 – $8.00.
Annual sales at Healthcare sector company grew by 12.29% over the past five years. When this article was written, the company’s average yearly earnings per share was at 84.04%. With a float of $4.10 million, this company’s outstanding shares have now reached $4.10 million.
60 Degrees Pharmaceuticals Inc (SXTP) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward 60 Degrees Pharmaceuticals Inc stocks. The insider ownership of 60 Degrees Pharmaceuticals Inc is 3.19%, while institutional ownership is 1.01%. The most recent insider transaction that took place on Dec 15 ’25, was worth 7,759. In this transaction President and CEO of this company bought 9,670 shares at a rate of $0.80, taking the stock ownership to the 59,618 shares. Before that another transaction happened on Dec 10 ’25, when Company’s President and CEO bought 9,350 for $0.95, making the entire transaction worth $8,886. This insider now owns 46,335 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -8.48 earnings per share (EPS) during the time that was less than consensus figure (set at -3.25) by -5.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 70.24% during the next five years compared to 12.29% growth over the previous five years of trading.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
You can see what 60 Degrees Pharmaceuticals Inc (SXTP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.32, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) saw its 5-day average volume 0.26 million, a negative change from its year-to-date volume of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 14.12%.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 1.61%, which indicates a significant decrease from 4.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0754 in the past 14 days, which was lower than the 0.0840 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0923, while its 200-day Moving Average is $1.7437. Nevertheless, the first resistance level for the watch stands at $0.6760 in the near term. At $0.7990, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8710. If the price goes on to break the first support level at $0.4810, it is likely to go to the next support level at $0.4090. Assuming the price breaks the second support level, the third support level stands at $0.2860.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
There are 4,230K outstanding shares of the company, which has a market capitalization of 2.34 million. As of now, sales total 680 K while income totals -7,950 K. Its latest quarter income was 530 K while its last quarter net income were -2,320 K.
